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Macrophage colony-stimulating factor has not been
considered as a factor responsible for dendritic cell or
Langerhans cell development from hematopoietic pro-
genitor cells. In this study, we examined whether
macrophage colony-stimulating factor could be used
instead of granulocyte-macrophage colony-stimulating
factor for the in vitro development of Langerhans cells
from hematopoietic progenitor cells.We replaced gran-
ulocyte-macrophage colony-stimulating factor with
macrophage colony-stimulating factor from a serum-
free culture containing granulocyte-macrophage col-
ony-stimulating factor, stem cell factor, Flt3 ligand,
tumor necrosis factor-a, and transforming growth
factor-b1. This serum-free culture medium containing
macrophage colony-stimulating factor, but not granu-
locyte-macrophage colony-stimulating factor (macro-
phage colony-stimulating factor culture), could induce
CD1aþ Birbeck granuleþ Langerinþ E-cadherinþ fac-
tor-like XIIIa Langerhans cells. As a control, the cul-
ture of hematopoietic progenitor cells in this culture
medium depleted of macrophage colony-stimulating
factor or transforming growth factor-b1 resulted in far
fewer or null CD1aþ cells, respectively. Macrophage
colony-stimulating factor increased the number of
CD1aþ cells in a concentration-dependent fashion.
These macrophage colony-stimulating factor-induced
Langerhans cells were di¡erent from granulocyte-
macrophage colony-stimulating factor-induced Lan-
gerhans cells in their decreased expression of CD11c
and their immature phenotype. The decreased expres-
sion of CD11c, however, was recovered by culturing
them with granulocyte-macrophage colony-stimulat-
ing factor, while they acquired a mature phenotype
qby granulocyte-macrophage colony-stimulating fac-
tor, tumor necrosis factor-a, interleukin-1a, or lipo-
polysaccharide. Macrophage colony-stimulating factor-
induced Langerhans cells could stimulate allogeneic T
cells. Interestingly, we could keep the growth and im-
mature phenotypes of macrophage colony-stimulating
factor-induced Langerhans cells for at least 28 d of
culture. These studies demonstrated that macrophage
colony-stimulating factor in cooperation with trans-
forming growth factor-b1 could induce Langerhans cell
development from hematopoietic progenitor cells in vi-
tro without granulocyte-macrophage colony-stimulat-
ing factor, which suggests the possibility that
macrophage colony-stimulating factor plays a part in
the Langerhans cell development in vivo. In addition,
the culture using macrophage colony-stimulating factor
presents a novel culture system to enable a large-scale
and long-term culture of immature Langerhans cells.
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R
ecent studies on dendritic cell (DC) growth and
di¡erentiation have revealed that di¡erent combi-
nations of hematopoietic growth factors, such as
granulocyte-macrophage colony-stimulating fac-
tors (GM-CSF), interleukin (IL)-3, tumor necrosis
factor (TNF)-a, stem cell factor (SCF), Flt3 ligand (Flt3L), and
transforming growth factor (TGF)-b, can generate DC in vitro
from bone marrow, cord blood, or adult blood CD34þ hemato-
poietic progenitor cells (HPC) (Caux et al, 1992; Reid et al, 1992;
Santiago-Schwarz et al, 1992; Romani et al, 1994; Bernhard et al,
1995; Siena et al, 1995; Szabolcs et al, 1995, 1996; Caux et al, 1996a,
b; Herbst et al, 1996; Rosenzwajg et al, 1996; Strobl et al, 1996;
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Strunk et al, 1996). In these studies, GM-CSF has been always
considered as an essential factor for DC growth and di¡erentia-
tion (Caux et al, 1992; Inaba et al, 1992, 1993; Young et al, 1995).
Therefore, most researchers include GM-CSF in their culture
medium. In contrast to GM-CSF, there is a controversy about
the e¡ects of M-CSF on DC growth and di¡erentiation. Xu
et al (1995) succeeded in generating long-term DC lines (XS
series) from murine epidermis. To establish and maintain these
cell lines, M-CSF produced by their feeder cell lines, called NS
lines, is indispensable (Takashima et al, 1995). Furthermore, they
demonstrated that XS lines as well as epidermal Langerhans cells
express M-CSF receptor, and that M-CSF stimulated the prolif-
eration of XS lines. In addition, Kamps et al (1999) have demon-
strated that, instead of GM-CSF, M-CSF also could induce DC in
conjunction withTNF-a and IL-4. Moreover, Dalloul et al (1999)
demonstrated that M-CSF augmented the production of DC
from cultures of thymic CD34þ CD1a cells with SCFþ
Flt3Lþ IL-7. In contrast, Menetrier-Caux et al (1998) reported
the inhibitory e¡ects of M-CSF or IL-6 produced by tumor cells
on DC di¡erentiation from CD34þ HPC. In this study, how-
ever, they always examined the e¡ects of M-CSF on DC di¡er-
entiation in cultures containing GM-CSF and TNF-a, they did
not examine the e¡ects of M-CSF alone on HPC. Recently, we
have demonstrated that a coculture of HPC with human cuta-
neous stromal cells that produce signi¢cant amounts of M-CSF
or with M-CSF induces CD1aþ CD14 DC without the addi-
tion of any other exogenous cytokines (Mollah et al, 2002). These
DC were CD1aþ E-cadherin (E-cad) Birbeck granule factor
XIIIaþ CD11bþ CD11cþ , although nearly half of them were
still CD14þ . These studies suggested that M-CSF induced at least
interstitial/dermal DC.
In this study, we hypothesized that M-CSF may replace the
role of GM-CSF in the in vitro development of Langerhans cells
from HPC. There are several ways to induce Langerhans cells in
vitro. Among them, we accepted the culture system that was re-
ported by Strobl et al (1997) and Gatti et al (2000), because it could
induce relatively immature Langerhans cells without fetal bovine
serum. Using this culture system, we replaced GM-CSF with M-
CSF. Interestingly, this serum-free culture medium containing
SCF, Flt3L, TNF-a, TGF-b1, and M-CSF could induce CD1aþ
Birbeck granuleþ Langerinþ E-cadþ factor XIIIa DCwithout
adding GM-CSF.We examined the role of M-CSF or TGF-b1 in
DC or Langerhans cell development in this culture system.
Furthermore, we compared the responses to maturation signals
and antigen-presenting functions between Langerhans cells in-
duced by GM-CSF and Langerhans cells induced by M-CSF.
MATERIALS AND METHODS
Media and reagents The medium used in the study was X-VIVO 15, a
serum free medium (BioWhittaker,Walkersville, MD).The bu¡er used for
the puri¢cation of HPC from the cord blood was phosphate-bu¡ered
saline supplemented with 1% bovine serum albumin (less than 1 ng per
mg of detectable endotoxin) (Sigma, St Louis, MO) and 5 mM
ethylenediamine tetraacetic acid (MACS bu¡er). We used the following
£uorescein isothiocyanate (FITC)-conjugated or phycoerythrin-conjugated
monoclonal antibodies for immunostaining: anti-CD1a antibody, anti-
CD14 antibody, anti-CD11b antibody (Dakopatts, Dakocytomation,
Glostrup, Denmark), anti-CD86 antibody, anti-cutaneous leukocyte
antigen antibody (BD PharMingen, San Diego, CA), anti-CD80
antibody, anti-HLA-DR antibody (BD PharMingen), anti-CD1a antibody,
anti-CD11c antibody, anti-CD83 antibody, anti-Langerin (CD207)
antibody, isotype-matched mouse IgM (Coulter, Hialeah, FL), and
isotype-matched mouse control antibodies (IgG1 and IgG2a from BD
PharMingen, and IgG2b from Ancell, Bayport, MN). We also used
nonlabeled monoclonal anti-human E-cad antibody (Takara Biomedicals,
Tokyo, Japan), anti-Birbeck granule-associated antigen antibody, Lag (gift
of Dr F. Furukawa, Hamamatsu University, Sizuoka, Japan), isotype
control antibody (IgG1) (Sigma), rat anti-human c-fms (M-CSF receptor,
CD115) monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA), control puri¢ed rat IgG2b (BD PharMingen), rabbit anti-
human factor XIIIa antibody (Berhingerwerke, Marburg, Germany), and
rabbit anti-factor VIII antibody (Dakopatts) as a negative control.
Recombinant human GM-CSF (41107 U per mg) was a gift from
Kirin Brewery Co. (Tokyo, Japan) and recombinant human M-CSF
(42105 U per mg), recombinant human TNF-a (42107 U per mg),
recombinant human SCF (45104 U per mg), recombinant humanTGF-
b1 (42107 U per mg), and recombinant human Flt3L (42105 U per
mg) were purchased from PepreoTech EC Ltd (London, U.K.).
Isolation of CD34þ HPC Umbilical cord blood samples were obtained
according to institutional guidelines. Cells bearing CD34 antigen were
isolated from mononuclear fractions through positive selection as
described (Jaksits et al, 1999). Brie£y, mononuclear cells were prepared by
discontinuous density gradient centrifugation using LymphoprepTM
(Nycomed Pharma As, Oslo, Norway). CD34þ HPC were isolated from
these mononuclear cells using a Direct CD34 Progenitor Cell Isolation Kit
(Miltenyi Biotec GmBH, Bergisch Gladbach, Germany) and MiniMACS
separation columns according to the manufacturer’s protocol.
Cell culture CD34þ cells (1104 per ml per well) were cultured in
X-VIVO 15 medium in 24-well tissue culture plates supplemented with
100 ng M-CSF per ml or 100 ng GM-CSF per ml, in conjunction with a
combination of 20 ng SCF per ml, 100 ng Flt3L per ml, 2.5 ngTNF-a per
ml, and 2.5 ngTGF-b1 per ml according to the methods described by Gatti
et al (2000). They were cultured without adding or changing the medium
or cytokines for 14 and 28 d for the culture with M-CSF in conjunction
with a combination of cytokines (M-CSF culture) and for 7, 10, 14, 18, 22,
and 28 d for the culture with GM-CSF in conjunction with a combination
of cytokines (GM-CSF culture). After culturing, cells were collected from
both types of cultures by vigorous pipetting to make single cell
populations or by gentle pipetting to harvest DC clusters. Clusters were
puri¢ed by gently harvesting cells with a pipette and layering on top of
6 ml of 7.5% bovine serum albumin (Sigma) in 15 ml tubes, and after
30 min on ice, single cells in suspension were removed by aspirating the
bovine serum albumin columns until 3.5 ml remained (Gatti et al, 2000).
Clusters were concentrated by centrifugation at 300 g, resuspended in
growth media, and used as cluster-puri¢ed Langerhans cells. Brie£y, to
clarify the role of M-CSF in this culture system, in some experiments: (i)
we cultured CD34þ cells with a combination of SCF, Flt3L,TNF-a, and
TGF-b1 with di¡erent concentrations of M-CSF or without M-CSF; (ii)
we measured the amount of M-CSF in the culture medium after 14 d of
culture; (iii) we examined the c-fms expression of day 14 M-CSF-induced
Langerhans cells (M-CSF Langerhans cells), those that were further
cultured for 24 h with a combination of cytokines, excluding M-CSF, and
day 7 G-CSF-induced Langerhans cells (G-CSF Langerhans cells); and (iv)
we added di¡erent concentrations of M-CSF or neutralizing anti-M-CSF
antibody (10 mg per ml; R&D Systems Inc., Minneapolis, MN) or isotype
control antibody (10 mg per ml; BD PharMingen) in the M-CSF culture
7 d after the beginning of the culture.We also cultured CD34þ cells with
GM-CSF or M-CSF in conjunction with a combination of cytokines,
excluding TGF-b1, to examine the role of TGF-b1. In some experiments,
we kept M-CSF culture by 30 d. In this culture period, when the cell
density increased, we subcultured the cells by splitting one well into three
wells.
Induction of maturation Clusters recovered from both culture systems
were stimulated to induce maturation by X-VIVO 15 containing 10 ng
TNF-a per ml, 10 ng IL-1b per ml, or 10 ng lipopolysaccharide (LPS) per
ml with or without 100 ng GM-CSF per ml or 100 ng M-CSF per ml.
These clusters were cultured for 48 h. After stimulation, the recovered
cells were analyzed by £ow cytometry.
Flow cytometry To determine the surface phenotypes of the cultured
HPC in both culture systems and those of Langerhans cells puri¢ed from
the clusters, which were induced to become mature by various
stimulations, the cells were treated with a combination of FITC-
conjugated antibody (10 mg per ml) and phycoerythrin-conjugated
antibody (10 mg per ml). For E-cad or c-fms expression, the cells were
¢rst incubated with anti-E-cad antibody or anti-c-fms antibody or
isotype-matched control antibody, and reacted with phycoerythrin-
conjugated anti-mouse or anti-rat immunoglobulins, respectively (Tago
Immunologicals, Camarillo, CA). After washing with phosphate-bu¡ered
saline supplemented with 1% bovine serum albumin and 0.02% NaN3
(£uorescence-activated cell sorter bu¡er), the cells were analyzed
by FACScan using CellQuest software (Beckton Dickinson, Franklin
Lakes, NJ). Dead cells were gated out after staining with 0.5 mg per ml
of propidium iodide solution. In these experiments, we used
unpermeabilized cells.
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Endocytosis assay with FITC-dextran Cluster-puri¢ed M-CSF
Langerhans cells recovered after 14 d of culture (day 14 M-CSF
Langerhans cells) and GM-CSF-induced Langerhans cells (GM-CSF
Langerhans cells) after 6 d (day 6 G-CSF Langerhans cells) or 9 d of
culture (day 9 G-CSF Langerhans cells) were suspended in X-VIVO 15
medium with M-CSF or GM-CSF in conjunction with a combination of
cytokines, respectively. Then, we determined the endocytotic activity of
M-CSF Langerhans cells and GM-CSF Langerhans cells according to the
method of Sallusto et al (1995).
Confocal laser scanning microscopy Immunohistochemical analysis
of factor XIIIa and Lag expression was performed on cytospin slides for
the cells harvested from both culture systems. The slides were at ¢rst
¢xed and permeabilized by Fix & Perm Cell Permeabilization Kit (Caltag
Laboratories, An Der Grub, Austria). After blocking with goat serum, the
slides were treated either with Lag or nonreactive mouse IgG1 anti-
body followed by FITC-conjugated anti-mouse immunoglobulins (Tago
Immunologicals) or with anti-factor XIIIa or anti-factor VIII anti-
body followed by FITC-conjugated anti-rabbit immunoglobulins (Tago
Immunologicals). The slides were mounted in permaFluor (Lipshaw
Immunon, Pittsburgh, PA) containing 0.5 mg propidium iodide per ml,
and observed under a confocal microscope (Leica microscope and system
GmBH,Wetzlar, Germany).
Electron microscopy For electron transmission microscopy, cluster-
puri¢ed GM-CSF Langerhans cells or M-CSF Langerhans cells were
¢xed with 2.5% glutaraldehyde in 0.1 M cacodylate bu¡er (pH 7.4) and
post¢xed with 1% OsO4. After dehydration with graded ethanol, they
were embedded in Epon. Ultrathin sections were stained with lead citrate
and uranyl acetate, and studied using a JEOL 100S electron microscope
(Japan Electron Optics Laboratory Co. Ltd,Tokyo, Japan).
AllogeneicTcell stimulation Peripheral blood mononuclear cells were
obtained by Ficoll Paque (Pharmacia Corporation, Peapack, NJ) gradient
centrifugation of heparinized blood. These peripheral blood mononuclear
cells were treated with a panTcell isolation kit (Miltenyi Biotec) according
to the manufacturer’s protocol. These enriched T cells consisted of more
than 95% CD3þ cells. T cells (2105 cells per well) were cocultured
in 96-well £at-bottom microtiter plates with various numbers of
cluster-puri¢ed GM-CSF Langerhans cells or M-CSF Langerhans cells
unstimulated or stimulated by various combinations of cytokines. After
4 d of culture at 371C in a 5% CO2 humidi¢ed atmosphere, the cells
were pulsed with 1 mCi per ml of [3H]thymidine (Radiochemical Center,
Amersham, U.K.) for the last 16 h of culture. At the end of the culture
period, the cells were transferred on to glass ¢ber and [3H]thymidine
incorporation was measured using a liquid scintillation counter. The
results were expressed as the mean7SEM of triplicate cultures. To
decrease the background proliferation, Langerhans cells were irradiated
with 2000 rad with a Softex (Softex Co. Ltd,Tokyo, Japan).
Statistical analysis Statistical signi¢cance of the di¡erences in allogeneic
T cell stimulation was analyzed by using the repeated measure two-way
ANOVA among M-CSF-induced Langerhans cells and GM-CSF-induced
Langerhans cells that were further stimulated with or without TNF-a,
M-CSFþTNF-a, or GM-CSFþTNF-a. When signi¢cant di¡erences
among groups were found by ANOVA, this was followed by posthoc testing
with Fisher’s protected least signi¢cant di¡erence test.
RESULTS
M-CSF in conjunction with SCF, Flt3L,TNF-a, and TGF-b1
could induce HPC to Langerhans cells without GM-
CSF As reported by Strobl et al (1997) and Gatti et al (2000),
HPC that were cultured in X-VIVO 15 containing GM-CSF
and a cocktail of SCF, Flt3L, TNF-a, and TGF-b1 (GM-CSF
culture), expanded 71713-fold (mean7SEM) by 10 d. In this
culture, clusters of DC appeared at 4^5 d after the initiation
of culture and reached the maximum number and size by 10 d
(Fig 1a,c). When we cultured HPC in X-VIVO 15 containing
M-CSF and the same cocktail of cytokines (M-CSF culture),
clusters of DC appeared at 7^8 d after the initiation of culture
and they expanded 3376.8-fold (mean7SEM) by 14 d
(Fig 1b,d). The cells in M-CSF culture were not necessarily
more adherent or more macrophage-like than those in GM-CSF
culture.When we compared the numbers of recovered cells from
GM-CSF culture (day 10) with those from M-CSF culture (day
14), the numbers of recovered cells were always greater in the
GM-CSF culture than in the M-CSF culture (Table I).
Figure1. Either GM-CSF or M-CSF can induce clusters of DC from
HPC. CD34+ cells were cultured in X-VIVO 15 medium in 24-well tissue
culture plates supplemented with GM-CSF (a,c) or M-CSF (b,d), in con-
junction with a combination of SCF, Flt3L,TNF-a, and TGF-b1 according
to the methods described by Gatti et al (2000). They were cultured without
adding or changing the medium or cytokines for 7^10 d for the culture
with GM-CSF in conjunction with a combination of cytokines (GM-
CSF culture) and 14 d for the culture with M-CSF in conjunction with a
combination of cytokines (M-CSF culture). Original magni¢cation:
(a,b) 25; (c,d) 50. These ¢gures are representative of ¢ve independent
experiments.
Table I. Numbers of total cells and CD1aþ cells recovered from M-CSF and GM-CSF culture
Experiment Number of total recovered cells (105) % of CD1aþ cells Number of CD1aþ cells (105)
No. 1 M-CSF culture 3.2 84 2.7
GM-CSF culture 9.7 9.0 0.87
No. 2 M-CSF culture 2.4 72 1.7
GM-CSF culture 10.0 5.7 0.57
No. 3 M-CSF culture 5.2 60 3.1
GM-CSF culture 6.5 7.8 0.51
No. 4 M-CSF culture 1.4 62 0.86
GM-CSF culture 2.8 11 0.30
No. 5 M-CSF culture 4.4 34 1.5
GM-CSF culture 6.6 6 0.40
Total7 M-CSF culture/ 3.370.68/ 6278.3/ 1.970.41/
SEM GM-CSF culture 7.171.3 7.971.0 0.5370.10
CD34þ cells (1104 per ml per well) were cultured in X-VIVO 15 medium in 24-well tissue culture plates supplemented with M-CSF or GM-CSF, in conjunction
with a combination of SCF, Flt3L,TNF-a, andTGF-b1. After culture, cells were collected from both types of cultures by vigorous pipetting to make single cells, and then
the total recovered cells from each well were counted, and the number of recovered CD1aþ cells was calculated by using percentage of CD1aþ cells determined by £ow
cytometry. Each experiment demonstrates the data obtained from di¡erent donors.
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When they were examined for their expression of several
markers related to DC by £ow cytometry, both the GM-CSF
culture and M-CSF culture contained CD1aþ CD14 HLA-
DRþ E-cadþ cutaneous leukocyte antigenþ Langerinþ cells.
Unexpectedly, the percentage of CD1aþ cells was larger in the
M-CSF culture (62%78.3%) (mean7SEM) than in the GM-
CSF culture (7.9%71.0%) (Table I; Fig 2). In addition, both
cultures contained Lagþ cells but not factor XIIIaþ cells in the
immunohistochemical staining (Fig 3a). Consistent with these
results of immunohistologic staining, we found that 70% of the
cluster-puri¢ed cells from M-CSF culture contained rod-shaped
Birbeck granules (Fig 3b) similar to those from GM-CSF culture
(data not shown). These data suggested that the M-CSF culture
also induced Langerhans cells from HPC as in the GM-CSF
culture.We therefore abbreviated the CD1aþ cells derived from
GM-CSF culture and M-CSF culture as GM-CSF Langerhans
cells and M-CSF Langerhans cells, respectively. Furthermore,
when we compared the number of CD1aþ cells recovered from
the culture between the GM-CSF culture and the M-CSF
culture, the M-CSF culture was found to contain greater
Figure 2. The phenotypic comparison between Langerhans cells induced by the M-CSF containing medium and those induced by the GM-
CSF containing medium. CD34+ cells (1104 per ml per well) were cultured in X-VIVO 15 medium supplemented with M-CSF or GM-CSF in
conjunction with a combination of SCF, Flt3L,TNF-a, and TGF-b1. They were cultured without adding or changing the medium or cytokines for 14 d
for the M-CSF culture and 7^10 d for the GM-CSF culture. In every experiment, we employed both culture systems for a comparative study. After culture,
cells were collected from both types of cultures by vigorous pipetting and analyzed by £ow cytometry. Dead cells were gated out after staining with 0.5 mg
per ml of propidium iodide solution. This is a representative £ow cytometry of three independent experiments. The data for Langerin expression were
obtained from DC of a di¡erent donor. In some of the £ow cytometry data, there seem to be discrepancies between the described percentage of cells and
the actual numbers of positive signals in the lower right quadrant. In these cases, most of the positive signals overlapped with the x-axis.
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numbers of CD1aþ cells (1.970.4105) (mean7SEM) than did
the GM-CSF culture 0.5370.1105; (po0.05 by Mann^
Whitney U test) (Table I).
M-CSF Langerhans cells kept an immature phenotype
with suppressed CD11c expression even after 14 d of
culture There were several di¡erences in the surface
phenotypes between GM-CSF Langerhans cells and M-CSF
Langerhans cells (Fig 2). The percentage of CD11cþ cells
among CD1aþ cells was much smaller in M-CSF Langerhans
cells than in GM-CSF Langerhans cells. GM-CSF Langerhans
cells contained greater numbers of DC with mature phenotypes
expressing CD80, CD83, or CD86, than did M-CSF Langerhans
cells. The percentage of CD83þ cells among CD1aþ cells was
signi¢cantly smaller in M-CSF Langerhans cells (2.8370.40
in mean7SEM, n¼ 5) than in GM-CSF Langerhans cells
(21.974.9) (po0.05 by Mann^Whitney U test). These data
suggest that M-CSF Langerhans cells kept an immature
phenotype after 14 d of culture, whereas GM-CSF Langerhans
cells gradually acquired a mature phenotype even without
breakage of clusters. To con¢rm this observation, we examined
the incorporation of FITC-dextran by GM-CSF Langerhans
cells or M-CSF Langerhans cells (data not shown). Consistent
with the phenotypic analysis, day 6 Langerhans cells
incorporated a signi¢cant amount of FITC-dextran, whereas day
9 Langerhans cells lost this activity. In contrast, day 14 M-CSF
Langerhans cells could incorporate more FITC-dextran than day
6 Langerhans cells.
CD11c is one of the well-known surface markers that
characterize myeloid-derived DC (Canque et al, 1998; Ito et al,
1999; Rissoan et al, 1999) in humans and is exclusively expressed
by DC in mice (Metlay et al, 1990). Nevertheless, signi¢cant
numbers of M-CSF Langerhans cells did not express CD11c.
Therefore, to examine whether M-CSF Langerhans cells could
recover the expression of CD11c, we added M-CSF or GM-CSF
to the culture of clusters puri¢ed from the M-CSF culture.
Interestingly, GM-CSF could increase the percentages of
CD11cþ cells among CD1aþ cells, whereas M-CSF did not
increase the CD11cþ cells (data not shown).
M-CSF, but not GM-CSF, enables long-term culture of
immature Langerhans cells Initially, we recovered the cells
from GM-CSF culture after 10 d of culture according to the
studies by Strobl et al (1997) and Gatti et al (2000), and compared
them with the cells recovered from M-CSF culture after 14 d of
culture. Therefore, next, we tried to continue these cultures by
splitting one well into three wells twice a week for 28 d (Fig 4).
As reported by Gatti et al (2000), the GM-CSF culture increased
the number of Langerhans cells by 10^12 d (Fig 4a), and
thereafter, did not increase their number. Meanwhile, GM-CSF
Langerhans cells gradually acquired a mature phenotype with
augmented expression of CD80, CD83, and CD86 (Fig 4b). In
contrast, M-CSF Langerhans cells continued to increase their
number (Fig 4a) and kept immature phenotypes with almost
null expression of CD80, CD83, or CD86 (Fig 4b) and with the
ability to incorporate FITC-dextran (data not shown), at least by
28 d of culture.
M-CSF was essential in Langerhans cell di¡erentiation from
CD34þ cells in the serum-free culture in conjunction with
SCF, Flt3L, TNF-a, and TGF-b1 Next, to clarify the role of
M-CSF in the induction of CD1aþ cells, we added various
concentrations of M-CSF to the culture of CD34þ cells
together with a cocktail of cytokines (Fig 5). Without M-CSF,
CD34þ cells cultured with only a cytokine cocktail including
SCF, Flt3L,TNF-a, and TGF-b produced only 7% CD1aþ cells.
When we added various concentrations of M-CSF to the culture,
M-CSF increased the percentage of CD1aþ CD14 cells in a
concentration-dependent manner.
As we cultured CD34þ cells in M-CSF culture for 14 d
without changing the culture medium or adding any cytokines,
it is likely that M-CSF may not function in the later phase of
culture. To exclude this possibility, we at ¢rst measured the
amount of M-CSF in the culture medium after 14 d of culture.
The culture supernatants from ¢ve di¡erent experiments
contained 14.070.10 ng per ml (mean7SEM). Next, we
examined c-fms expression by M-CSF Langerhans cells or GM-
CSF Langerhans cells as a control (data not shown). Most of the
GM-CSF Langerhans cells expressed c-fms immediately after the
recovery from culture, whereas none of the M-CSF Langerhans
cells expressed it. After M-CSF Langerhans cells were cultured
for 24 h in X-VIVO 15 with a cytokine cocktail containing SCF,
Flt3L, TNF-a, and TGF-b, but not M-CSF; however, M-CSF
Langerhans cells expressed c-fms. Finally, when the M-CSF
culture was supplemented with di¡erent concentrations of M-
CSF or anti-M-CSF antibody after 7 d of culture, addition of
M-CSF did not necessarily increase the number of recovered
CD1aþ cells after 14 d of culture, whereas anti-M-CSF antibody
Figure 3. M-CSF culture also induces Lag+ cells, but not factor
XIIIa+ cells, and those containing Birbeck granules. (a) The cytospin
slides were at ¢rst ¢xed and permeabilized by Fix & Perm Cell Permeabi-
lization Kit. After blocking with goat serum, the slides were treated either
with Lag or nonreactive mouse IgG1 antibody followed by FITC-conju-
gated anti-mouse immunoglobulins or with anti-factor XIIIa or control
antibody (data not shown) followed by FITC-conjugated anti-rabbit im-
munoglobulins. The slides were mounted in permaFluor containing 0.5
mg propidium iodide per ml and observed under a confocal microscope.
These data are representative of three independent experiments. (b) The
cluster-puri¢ed DC from M-CSF culture were obtained from three di¡er-
ent donors as described in Materials and Methods. Cells were ¢xed and pro-
cessed for electron microscopy observations. This is a representative DC
from M-CSF culture (scale bar: 500 nm). The inset represents a higher mag-
ni¢cation of Birbeck granules (scale bar: 200 nm). M-CSF cultures con-
tained 70% cells with Birbeck granules in three independent experiments.
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signi¢cantly reduced their number (po0.05 by Mann^Whitney
U test) (data not shown).
The induction of Langerhans cells from CD34+ cells by
M-CSF culture was absolutely dependent on the presence of
TGF-b1 It has been demonstrated that TGF-b1was essential for
Langerhans cell development in vivo and in vitro, but not for DC
development (Strobl et al, 1996, 1997; Borkowski et al, 1997; Riedl
et al, 1997; Caux et al, 1999). Therefore, we examined the role of
TGF-b1 in the di¡erentiation of Langerhans cells from CD34þ
cells in the M-CSF culture or the GM-CSF culture (Fig 6).When
we depleted TGF-b1 from the GM-CSF culture, the culture
still produced CD1aþ cells, but they lost the Langerhans
cell phenotype such as Langerin. In contrast, when TGF-b1
was depleted from the M-CSF culture, it could not produce any
CD1aþ cells, or Langerinþ cells at all.
Induction of phenotypic maturation of M-CSF Langerhans
cells and GM-CSF Langerhans cells by various combina-
tions of cytokines Next, we examined whether several
stimulations that have been reported to induce DC maturation
(reviewed in Aiba, 1998; Banchereau and Steinman, 1998; Young,
1999) could induce the expression of maturation markers on M-
CSF Langerhans cells (Fig 7). At ¢rst, we cultured M-CSF
Langerhans cells in X-VIVO 15 without any exogenous
cytokines, with M-CSF, or with GM-CSF for 72 h. When
compared with the expression of the three maturation markers
on M-CSF Langerhans cells cultured without any cytokines, the
culture with GM-CSF increased the expression of all three
markers, whereas the culture of M-CSF suppressed them. Either
TNF-a or IL-1b alone also increased the expression of these three
markers, whereas LPS alone augmented the expression of CD83
and CD86.When GM-CSF was added to the culture with TNF-
a, IL-1b, or LPS, GM-CSF always augmented the expression of
CD80 and CD86 but not that of CD83. In contrast, M-CSF
always suppressed the expression of these three markers. On the
other hand, GM-CSF Langerhans cells were also induced to
upregulate these three markers by GM-CSF, whereas their
expression of these three markers were not signi¢cantly
suppressed by M-CSF. TNF-a or IL-1b alone augmented the
expression of CD83, and CD86, whereas LPS alone augmented
only CD86. When GM-CSF was added to the culture with
TNF-a, IL-1b, or LPS, GM-CSF augmented the expression of
CD80, CD83, and CD86 in the culture with TNF-a, that of
CD80 and CD86 in the culture with IL-1b, and that of CD80,
CD83, and CD86 in the culture with LPS. Again, M-CSF did
not a¡ect the expression of these three markers in the culture
with TNF-a, IL-1b, or LPS.
Allogeneic T cell stimulation by M-CSF Langerhans cells
and GM-CSF Langerhans cells stimulated by various
combinations of cytokines We studied the antigen-
presenting function of M-CSF Langerhans cells and GM-CSF
Langerhans cells and that of the Langerhans cells cultured with
cytokines (Fig 8). As the GM-CSF culture and the M-CSF
culture contained greatly di¡ering numbers of Langerhans cells,
we used the cluster-puri¢ed Langerhans cells from the GM-CSF
culture or M-CSF culture. They were composed of more than
70% CD1aþ cells in every experiment (data not shown). In this
study, to maintain the viability of GM-CSF Langerhans cells and
M-CSF Langerhans cells, we cultured the clusters puri¢ed from
the GM-CSF culture or those from M-CSF culture with M-CSF
or GM-CSF without a cocktail of cytokines. M-CSF Langerhans
cells could stimulate signi¢cant T cell proliferation even after
the culture with M-CSF, although the magnitude of T cell
proliferation induced by M-CSF Langerhans cells after the
preculture with M-CSF was smaller than that induced by
GM-CSF Langerhans cells after the preculture with GM-CSF.
M-CSF Langerhans cells precultured with GM-CSF alone
augmented their antigen-presenting function (p¼ 0.0275:
M-CSF Langerhans cells treated with M-CSF vs M-CSF
Langerhans cells treated with GM-CSF). When M-CSF
Langerhans cells were cultured with a combination of
GM-CSFþTNF-a or M-CSFþTNF-a, they stimulated
Figure 4. M-CSF enables long-term culture of
immature Langerhans cells.The GM-CSF culture
and the M-CSF culture were continued by splitting
one well into three wells twice a week for 28 d. After
various time periods, cells were collected from both
types of cultures by vigorous pipetting to make sin-
gle cells, and then the total recovered cells were
counted, and the number of recovered CD1a+ cells
was calculated by using percentage of CD1a+ cells
determined by £ow cytometry (a). After 28 d of cul-
ture, the expression of CD80, CD83, and CD86 was
examined by £ow cytometry (b). In some of the £ow
cytometry data, there seem to be discrepancies be-
tween the described percentage of cells and the ac-
tual numbers of positive signals in the lower right
quadrant. In these cases, most of the positive signals
overlapped with the x-axis.
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signi¢cantly more vigorous T cell proliferation than did those
cultured with M-CSF alone (p¼ 0.0053: M-CSF Langerhans
cells treated with M-CSF vs M-CSF Langerhans cells treated
with M-CSFþTNF-a; po0.0001: M-CSF Langerhans cells
treated with M-CSF vs M-CSF Langerhans cells treated with
GM-CSFþTNF-a). There were no signi¢cant di¡erences in
the allogeneic T cell stimulation among GM-CSF Langerhans
cells precultured with GM-CSF alone and GM-CSFþTNF-a.
GM-CSF Langerhans cells precultured with M-CSF alone
induced signi¢cantly weaker T cell proliferation than did
those precultured with GM-CSF alone (po0.0001: GM-CSF
Langerhans cells treated with GM-CSF vs GM-CSF Langerhans
cells treated with M-CSF; p¼ 0.0077).
DISCUSSION
In this study, we found two important functions of M-CSF and a
unique role of TGF-b1 in Langerhans cell or DC development.
First, it has become clear that M-CSF can replace the role of
GM-CSF in Langerhans cell development in vitro in the presence
of TGF-b1. Although several papers suggested the role of M-CSF
in DC development (Takashima et al, 1995; Xu et al, 1995; Dalloul
et al, 1999; Kamps et al, 1999), M-CSF has not been considered as a
crucial factor responsible for DC or Langerhans cell development
from HPC. In this study, we found that, although a combination
of TNF-a, Flt3L, SCF, and TGF-b could not induce signi¢cant
Langerhans cell development from HPC, M-CSF could induce
Langerhans cell development such as GM-CSF when it was
added to the culture. These Langerhans cells ful¢lled the major
criteria of Langerhans cells, such as the expression of CD1a,
HLA-DR, CD11c, Langerin, Lag, and E-cad, the presence of Bir-
beck granules, the lack of expression of factor XIIIa, active endo-
cytosis in the immature state, and phenotypic and functional
maturation with augmented expression of CD80, CD83, and
CD86, in addition to increased antigen-presenting function.
These ¢ndings clearly indicated that GM-CSF is not the only
essential factor for DC or Langerhans cell development, but that
M-CSF also can function like GM-CSF in Langerhans cell devel-
opment from HPC in the presence of TGF-b1, at least in vitro.
Furthermore, this study demonstrated the role of M-CSF in
Langerhans cell maturation. One of the major di¡erences be-
tween GM-CSF Langerhans cells and M-CSF Langerhans cells
was the expression of CD80, CD83, and CD86 and the incor-
poration of FITC-dextran. Namely, the M-CSF culture contained
much less CD80, CD83, or CD86þ cells than did the GM-CSF
culture. In addition, GM-CSF Langerhans cells could incorporate
signi¢cant amounts of FITC-dextran 6 d after culture, whereas
they lost this ability 9 d after culture. In contrast, M-CSF Langer-
hans cells even 14 d after culture could incorporate similar
amounts of FITC-dextran to GM-CSF Langerhans cells recov-
ered 6 d after culture. In addition, when we added M-CSF in
the second culture of Langerhans cell clusters recovered from
M-CSF culture, M-CSF clearly suppressed the spontaneous ma-
turation of Langerhans cells or their maturation induced by IL-
1b, TNF-a, or LPS. These data suggest that, whereas GM-CSF
induces both Langerhans cell development and maturation,
M-CSF mediates only Langerhans cell development and rather
suppresses Langerhans cell maturation. Therefore, when we con-
tinued M-CSF culture for a much longer period, we could ex-
pand immature Langerhans cells at least by 28 d of culture and
obtain 4.070.5106 cells from the culture of 1104 CD34þ
HPC. Interestingly, although M-CSF Langerhans cells are pheno-
typically immature and less potent than GM-CSF Langerhans
cells in allogeneic T cell stimulation, they can acquire a mature
phenotype and become as potent as GM-CSF Langerhans cells by
stimulation with GM-CSF, IL-1b, TNF-a, or LPS in the absence
of M-CSF. These observations indicate that M-CSF Langerhans
cells, although they are immature, are not functionally defective.
In addition, in this study, we also clari¢ed further the role of
GM-CSF in the induction of CD11c. CD11c is considered one of
the markers of myeloid DC (Canque et al, 1998; Ito et al, 1999;
Rissoan et al, 1999) in humans and is exclusively expressed by
DC in mice (Metlay et al, 1990). The percentage of CD11c in M-
CSF Langerhans cells was signi¢cantly lower than that in GM-
CSF Langerhans cells.When we further cultured M-CSF Langer-
hans cells with the medium containing GM-CSF, these Langer-
hans cells began to show the expression of CD11c, which
suggested the crucial role of GM-CSF in the induction of
Figure 5. M-CSF induces CD1a expression on HPC cultured with a
combination of SCF, Flt3L,TNF-a, and TGF-b1 in a concentration-
dependent manner. CD34+ cells (1104 per ml per well) were cultured
in X-VIVO 15 medium supplemented with various concentrations of M-
CSF in conjunction with a combination of SCF, Flt3L,TNF-a, and TGF-
b1. After 14 d of culture, the cells were recovered from the culture and ex-
amined for the expression of CD1a and CD14 by £ow cytometry. These
data are representative of three independent experiments.
Figure 6. M-CSF could not support Langerhans cell or DC devel-
opment without TGF-b1, whereas GM-CSF could support DC, but
not Langerhans cell development without TGF-b1. We cultured
CD34+ cells with GM-CSF or M-CSF in conjunction with the combina-
tion of cytokines including or excluding TGF-b1 to examine the role of
TGF-b1. After 9 d of culture for the GM-CSF culture and 14 d of culture
for the M-CSF culture, the expression of CD1a, CD14, or Langerin was
examined by £ow cytometry. In some of the £ow cytometry data, there
seem to be discrepancies between the described percentage of cells and the
actual numbers of positive signals in the lower right quadrant. In these
cases, most of the positive signals overlapped with the x-axis. These data
are representative of three independent experiments.
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CD11c. These ¢ndings disclosed a signi¢cant di¡erence between
DC development by GM-CSF and that by M-CSF.
When we depleted TGF-b1 from the M-CSF culture or GM-
CSF culture, however, a signi¢cant di¡erence between M-CSF
and GM-CSF in terms of Langerhans cell development became
clear. The GM-CSF culture could induce CD1aþ DC even with-
out TGF-b1, although these CD1aþ cells lacked the phenotype of
Langerhans cells. In contrast, the M-CSF culture could not in-
duce any CD1aþ DC in the absence of TGF-b1. Several recent
studies have identi¢edTGF-b as a mandatory factor for the devel-
opment of Langerhans cells both in vitro and in vivo. In particular,
TGF-b-de¢cient mice lack Langerhans cells in the epidermis,
Figure 7. Various combinations of cytokines induce the phenotypic maturation of GM-CSF Langerhans cells and M-CSF Langerhans cells
di¡erently. GM-CSF Langerhans cells (a) and M-CSF Langerhans cells (b) were unstimulated or further stimulated with M-CSF or GM-CSF in conjunc-
tion with TNF-1a, IL-1b, or LPS for 48 h. After stimulation, the cells were examined for the expression of CD80, CD83, or CD86 by £ow cytometry.
These data are representative of three independent experiments.
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whereas other DC populations appear normal (Borkowski et al,
1997). Also, in humans, TGF-b is required for the development
of Langerhans cells from HPC in serum-free culture (Strobl et
al, 1996, 1997; Riedl et al, 1997; Caux et al, 1999). As these studies
were performed in the presence of GM-CSF, however, it is not
clear whether TGF-b1 has a similar e¡ect on Langerhans cell or
DC development in the absence of GM-CSF. Our present studies
clearly demonstrated that TGF-b1 could also shift the di¡erentia-
tion of HPC to Langerhans cells even in a culture containing M-
CSF but not GM-CSF.
Through these studies, we raised the question of which cyto-
kines really function in DC development from HPC in vivo. In-
itially, the possibility of M-CSF playing a part in DC
development was denied by several studies using op/op mice (Ta-
kahashi et al, 1993; Witmer-Pack et al, 1993; Usuda et al, 1994),
which cannot produce functional M-CSF. Normal di¡erentiation
of DC or Langerhans cells in these mice lacking M-CSF was de-
monstrated, which suggested the crucial role of GM-CSF in Lan-
gerhans cell development, although reduced density (Witmer-
Pack et al, 1993) and an abnormal morphology (Takahashi et al,
1993) of epidermal Langerhans cells were also reported. In both
GM-CSF null mice and GM-CSF receptor b chain null
mice, however, DC and Langerhans cells were present in all the
lymphoid organs and the epidermis, respectively, although a
reduced density of Langerhans cells in the steady state and
delayed recovery of Langerhans cells after LPS depletion were
recognized (Vremec et al, 1997; Burnham et al, 2000). These
studies could not determine which cytokine, M-CSF or
GM-CSF, really functions for DC or Langerhans cell develop-
ment in vivo. So far, we do not have any concrete evidence
to answer these questions. There remains the possibility that
factor(s) other than GM-CSF or M-CSF might be responsible
for DC development in vivo.
Finally, there was a signi¢cant di¡erence in percentage of
CD1aþ cells in GM-CSF culture between the data reported by
Strobl et al (1997) and Gatti et al (2000), and this study. Namely,
the former reported that their GM-CSF culture contained
64%74% and 35^64% of CD1aþ cells, respectively, whereas in
our experiments, the same culture condition contained less than
10% of CD1aþ cells. So far, we did not ¢nd any reasonable ex-
planation for this discrepancy. Therefore, although this study
clearly demonstrated that M-CSF culture enabled us to produce
more CD1aþ cells from HPC than GM-CSF culture, at present
we should wait to make a de¢nite conclusion on the di¡erence in
the e⁄cacy of GM-CSF culture and M-CSF culture to produce
Langerhans cells.
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